Non-Interventional Research Investigators
Bristol-Myers Squibb considers requests for clinical research trials from all clinical and therapeutic areas, and gives priority to proposals that support our medical plans in the following therapeutic areas: cardiovascular/metabolics, neuroscience, cancer, immunology and virology.
Objectives
The Bristol-Myers Squibb ISR application process provides a framework and allows investigators to work from a common set of criteria, requirements and schedule of events. The process is designed to ensure scientific rigor and patient safety while supporting unique research ideas and providing insights into areas of unmet medical need.
Disclaimer
Requests for Research Proposals are not to be interpreted as suggesting that any product is safe or effective for an investigational use or recommended for any use outside of its approved labeling. Bristol-Myers Squibb does not guarantee support. Please note that studies may be submitted for “drug-only” support as well as drug & funding support. Support is solely recognized at the time of full execution of the clinical research agreement.
| Cardiovascular/Metabolics |
ONGLYZA™ (saxagliptin) Partnered with AstraZeneca
PLAVIX® (clopidogrel bisulfate) Partnered with Sanofi-aventis
Please note that PLAVIX® (clopidogrel bisulfate) and ONGLYZA™ (saxagliptin) do not have any research proposals posted at this time, however, you may submit your research concept by clicking here. |
| Immunoscience |
Belatacept
ORENCIA® (abatacept)
Please note that Belatacept and ORENCIA® (abatacept) do not have any research proposals posted at this time, however, you may submit your research concept by clicking here. |
| Neuroscience |
ABILIFY® (aripiprazole) Partnered with Otsuka Pharmaceutical Co., Ltd.
Please note that ABILIFY® (aripiprazole) does not have any research proposals posted at this time, however, you may submit your research concept by clicking here. |
| Oncology |
ERBITUX® (cetuximab) Partnered with Eli Lilly
Ipilimumab
IXEMPRA® (ixabepilone)
SPRYCEL® (dasatinib)
Please note that ERBITUX® (cetuximab), Ipilimumab, IXEMPRA® (ixabepilone) and SPRYCEL® (dasatinib) do not have any research proposals posted at this time, however, you may submit your research concept by clicking here. |
| Virology |
ATRIPLA® (efavirenz / emtricitabine / tenofovir disoproxil fumarate) Partnered with Gilead
REYATAZ® (atazanavir sulfate)
SUSTIVA® (efavirenz)
BARACLUDE® (entecavir) |
Click here for trademark information on Bristol-Myers Squibb products.
Please click here to agree and return to a saved application.